Dextrose | Glucose-SOLOpharm Polyflack Domus 5% plastic 200 ml

Special Price $13.58 Regular Price $22.00
In stock
SKU
BID828856
271.6 Reward Points will be used to purchase this product
Pharmacological action

Participates in various metabolic processes in the body.

Infusion of dextrose solutions partially replenishes the water deficit.

Dextrose, entering the tissue, phosphorylates, turning into glucose-6-phosphate, which is actively involved in many parts of the body's metabolism. A 5% dextrose solution is isotonic with blood plasma. Hypertonic solutions (10%, 20%, 40%) increase the osmotic pressure of the blood, increase diuresis.

Theoretical osmolarity of 10% dextrose - 555 mOsm / l, 20% - 1110 mOsm / l.
Pharmacological action

Participates in various metabolic processes in the body.

Infusion of dextrose solutions partially replenishes the water deficit.

Dextrose, entering the tissue, phosphorylates, turning into glucose-6-phosphate, which is actively involved in many parts of the body's metabolism. A 5% dextrose solution is isotonic with blood plasma. Hypertonic solutions (10%, 20%, 40%) increase the osmotic pressure of the blood, increase diuresis.

Theoretical osmolarity of 10% dextrose - 555 mOsm / l, 20% - 1110 mOsm / l.

Indications

hypoglycemia

carbohydrate malnutrition

toxicoinfection

intoxication in liver diseases (hepatitis, dystrophy and atrophy of the liver, including hepatic failure)

hemorrhagic diathesis srdlprdkrdprrdpkrdprrdpdrklpdrklpdrklpdrklpdrklpdrklpdrklpdrklpdrklpdrklpdrklpdrklpdrklpdrklpdrklpdrklpdrklpdrklpdrklpdrkdrkp shock.

Contraindications

hyperglycemia

hyperlactacidemia

hyperhydration

postoperative disorders of glucose utilization

circulatory disorders that threaten cerebral and pulmonary edema

acute cerebrospinal ulcer hypersensitivity.

Precautions: decompensated chronic heart failure, chronic renal failure (oligo-, anuria), hyponatremia, diabetes mellitus.

Special instructions

Monitoring electro-electrolyte balance.

To increase osmolarity, a 5% solution can be combined with an isotonic sodium chloride solution.

For a more complete and fast absorption of glucose, administered in large doses, at the same time, s / c 4-5 IU of short-acting insulin can be administered at the rate of 1 IU of insulin per 4-5 g of glucose.

Patients with diabetes mellitus are administered glucose under the control of its content in the blood and urine.

Influence on the ability to drive vehicles and control mechanisms

Adverse effects on the ability to drive vehicles and work with mechanisms have not been identified.

Composition

1 ml dextrose 0.05 g

Excipients:

sodium chloride 0.00026 g,

hydrochloric acid solution 0.1 M to pH 3.0 - 4.1,

water d / and up to 1 ml.

Theoretical osmolarity 277 mOsm / l

Side effects

Hypervolemia, acute left ventricular failure if the rate of administration is exceeded - osmotic diuresis with loss of water, electrolytes and the development of hyperosmolar coma.

At the injection site - the development of infection, thrombophlebitis.

Overdose

Symptoms: hyperglycemia, glucosuria, hyperglycemic, hyperosmolar coma, hyperhydration, imbalance of water-electrolyte balance, increased liponeogenesis with increased CO2 production, which leads to a sharp increase in respiratory respiratory rate and fatty liver, as a result.

Treatment: stop administering glucose, administer short-acting insulin, symptomatic therapy.

Storage conditions

At a temperature of 5 to 30 РC. Keep out of the reach of children.

Expiration

3 years

Terms and conditions

prescription

dosage form

infusion solution

Appointment

Nursing Moms, Pregnant By Prescription, Kids By Prescription, Adults By On nacheniyu Vracha

Submit your review to Earn 10 Reward Points click here to login

Write Your Own Review
You're reviewing:Dextrose | Glucose-SOLOpharm Polyflack Domus 5% plastic 200 ml

 Job in company (10-20 minutes a day | 400 - 1200 USD)! 

We are looking for partners!

 If you have PayPal and you are ready to earn in our team - contact us: [email protected] 

Copyright © 2011-2024 Buy-Pharm, Inc. All rights reserved.